We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,014 results
  1. Role of the RAAS in mediating the pathophysiology of COVID-19

    The renin-angiotensin-aldosterone system (RAAS) holds a position of paramount importance as enzymatic and endocrine homeostatic regulator concerning...

    Jakub Jasiczek, Adrian Doroszko, ... Małgorzata Trocha in Pharmacological Reports
    Article Open access 23 April 2024
  2. Emerging roles of ferroptosis in liver pathophysiology

    Ferroptosis is a widely recognized process of regulated cell death linking redox state, metabolism, and human health. It is considered a defense...

    Kyu Min Kim, Sam Seok Cho, Sung Hwan Ki in Archives of Pharmacal Research
    Article 20 October 2020
  3. Expand the treatment horizon of premenstrual dysphoric disorder with targeted therapeutic approaches

    Premenstrual dysphoric disorder (PMDD) is a sex-specific cyclic mood disorder characterized by heterogenous mood and physical symptoms during the...

    Article 01 January 2024
  4. Manage idiopathic hypersomnia with a combination of non-pharmacological and pharmacological treatments

    Idiopathic hypersomnia (IH) is a rare slee** disorder that is difficult to diagnose, and little is known about its pathophysiology. A defining...

    Article 03 October 2023
  5. Current and emerging immunobiologic therapies for atopic dermatitis

    Atopic dermatitis (AD) is a chronically relapsing inflammatory skin disease with a multifactorial etiology that affects up to 20% of children and up...

    Hemali Shah, Francelia J. Eckembrecher, ... Keyvan Nouri in Drugs & Therapy Perspectives
    Article Open access 13 June 2024
  6. Mechanisms of norcantharidin against renal tubulointerstitial fibrosis

    Renal tubulointerstitial fibrosis (RTIF) is a common feature and inevitable consequence of all progressive chronic kidney diseases, leading to...

    Qin-Su Yun, Yu-**n Bao, ... Qian Guo in Pharmacological Reports
    Article 12 March 2024
  7. Colchicine may be considered for the secondary prevention of cardiovascular disease

    The acknowledgement of the significant role of inflammation in the pathophysiology of atherosclerosis has led to the investigation of...

    Esther S. Kim, Arnold Lee in Drugs & Therapy Perspectives
    Article 27 March 2023
  8. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies

    The desire to find a gold-standard therapy for depression is still ongoing. Develo** one universal and effective pharmacotherapy remains...

    Barbara Chruścicka-Smaga, Agata Machaczka, ... Andrzej Pilc in Pharmacological Reports
    Article Open access 07 November 2023
  9. Role of Neutrophils as Therapeutic Targets in Intracerebral Hemorrhage

    Intracerebral hemorrhage (ICH) is a major health problem. It is one of the most common types of stroke and results in mortality in approximately half...

    Alper Fatih Ardic, Nurittin Ardic in Therapeutic Innovation & Regulatory Science
    Article 16 May 2024
  10. Mechanistic correlation of molecular pathways in obesity-mediated stroke pathogenesis

    Obesity, a prominent risk factor for the development of heart attacks and several cardiovascular ailments. Obesity ranks as the second most...

    Heena Khan, Chanchal Tiwari, ... Thakur Gurjeet Singh in Pharmacological Reports
    Article 18 April 2024
  11. Intervention of Phytochemicals During Endometriosis and Their Conceivable Mechanisms

    Endometriosis is a chronic and complex endocrine disorder that affects women of reproductive age. This syndrome is benign and is characterized by a...

    Safiya Ayesha, Alka Sharma, ... Anima Tripathi in Revista Brasileira de Farmacognosia
    Article 19 July 2023
  12. Targeting toxic forms of α-synuclein with immunotherapy could alter the progression of Parkinson’s disease

    α-Synuclein is a presynaptic protein typically involved in synaptic regulation. However, it may form toxic aggregates and propagate in the CNS via...

    Article 18 October 2022
  13. Deucravacitinib in plaque psoriasis: a profile of its use

    Deucravacitinib (SOTYKTU™) is a tyrosine kinase 2 (TYK2) inhibitor that expands the availability of effective oral treatments for the management of...

    Article 01 November 2023
  14. Potential of Nanoencapsulated Quercetin Topical Formulations in the Management of Diabetic Foot Ulcer

    Diabetic foot ulcer originates due to peripheral neuropathy, immunosuppression, resistance to infections, and peripheral arterial disease. The...

    Shashank Chaturvedi, Shruti Agrawal, ... Vaibhav Rastogi in Revista Brasileira de Farmacognosia
    Article 28 December 2022
  15. Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention

    Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin–angiotensin–aldosterone system pathway, and...

    Ekta Shirbhate, Jaiprakash Pandey, ... Harish Rajak in Pharmacological Reports
    Article 27 June 2021
  16. Use of glucocorticoids and azithromycin in the therapy of COVID-19

    In December 2019, a new variant coronavirus, SARS-CoV-2, emerged in China, which was initially described as a pneumonia of an unknown agent. The new...

    Miguel de Lemos Neto, Rafael Costa Vieira Alexandre, ... Pedro Celso Braga Alexandre in Pharmacological Reports
    Article 04 June 2021
  17. The impact of brivaracetam on cognitive processes and anxiety in various experimental models

    Background

    Memory deficits and anxiety symptoms are undesirable effects that occur in epilepsy patients. They may be associated with the...

    Ewa Zwierzyńska, Bogusława Pietrzak in Pharmacological Reports
    Article Open access 05 January 2024
  18. Targeting the CCL2-CCR2 axis in depressive disorders

    Since affective disorders are considered to be underlain by the immune system malfunction, an important role in their pathophysiology is assigned to...

    Katarzyna Curzytek, Monika Leśkiewicz in Pharmacological Reports
    Article Open access 24 May 2021
  19. Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease

    α-Synuclein oligomers and Ca 2+ dyshomeostasis have been thoroughly investigated with respect to the pathogenesis of Lewy body disease (LBD). In LBD,...

    Kenji Yamamoto in Archives of Pharmacal Research
    Article Open access 10 June 2021
Did you find what you were looking for? Share feedback.